This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
EverQuote, Inc. (EVER) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
EverQuote, Inc. (EVER) delivered earnings and revenue surprises of 16.67% and 5.42%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
EverQuote, Inc. (EVER) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
EverQuote, Inc. (EVER) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Should You Hold Hartford Financial in Your Portfolio?
by Zacks Equity Research
Riding on its rising investment income, strategic initiatives and capital position, Hartford Financial (HIG) holds promise to reap benefits for investors.
Radian Group Steps Up Safety Measures Amid Coronavirus Outbreak
by Zacks Equity Research
Radian Group (RDN) takes precautionary steps against the novel coronavirus pandemic to ensure safety of its employees and customers.
EverQuote (EVER) Q4 Loss Narrower Than Expected, Revenues Beat
by Zacks Equity Research
EverQuote's (EVER) Q4 results reflect strong growth in consumer quote request volume and impressive performance across its insurance verticals.
EverQuote, Inc. (EVER) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
EverQuote, Inc. (EVER) delivered earnings and revenue surprises of 33.33% and 8.16%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
What's in the Cards for EverQuote's (EVER) Q4 Earnings?
by Zacks Equity Research
EverQuote's (EVER) Q4 results are likely to reflect revenue growth and expansion in EBITDA.
Expand Your Portfolio with this First Profit Stock Screener
by Benjamin Rains
We are in the midst of the fourth quarter earnings season. This makes it a great time to use our 'First Profit' stock screener. The idea is to search for companies that recently reported their first quarterly profit...
Is EverQuote (EVER) Outperforming Other Finance Stocks This Year?
by Zacks Equity Research
Is (EVER) Outperforming Other Finance Stocks This Year?
Sea Limited (SE) Looks Good: Stock Adds 7.4% in Session
by Zacks Equity Research
Sea Limited (SE) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.
Prudential's (PRU) Unit Expands Travel Assistance Offerings
by Zacks Equity Research
Prudential's (PRU) arm chooses IMG to upgrade its travel assistance suite and a new insurance product.
The Zacks Analyst Blog Highlights: EverQuote, Cassava Sciences, Fulgent Genetics, Teekay Tankers and Cue Biopharma
by Zacks Equity Research
The Zacks Analyst Blog Highlights: EverQuote, Cassava Sciences, Fulgent Genetics, Teekay Tankers and Cue Biopharma
5 Stocks to Soar in 2020 After Solid Gains in 2019
by Zacks Equity Research
U.S. stocks rallied to attained fresh all-time highs in 2019, as the momentum continued in 2020. Here are five stocks that are poised to grow.
Is EverQuote (EVER) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Is (EVER) Outperforming Other Finance Stocks This Year?
Reasons Why Investors Should Buy MGIC Investment (MTG) Stock
by Zacks Equity Research
MGIC Investment (MTG) is poised to grow on the back of lower claims payments and prudent capital deployment.
Here's Why Investors Should Hold on to Aflac (AFL) Stock
by Zacks Equity Research
Aflac (AFL) is poised for growth on the back of favorable performance in its U.S. business and a strong capital position despite softness in Japan business.
EverQuote, Inc. (EVER) Is Up 7.1% in One Week: What You Should Know
by Zacks Equity Research
Does EverQuote, Inc. (EVER) have what it takes to be a top stock pick for momentum investors? Let's find out.
Here's Why Radian Group (RDN) Stock is an Attractive Bet
by Zacks Equity Research
Radian Group (RDN) remains poised for growth on improved mortgages insurance and lower levels of paid claims.
EverQuote, Inc. (EVER) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
EverQuote, Inc. (EVER) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
EverQuote, Inc. (EVER) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in EverQuote, Inc. (EVER).
5 Stocks That Pushed Russell 2000 ETF Higher
by Sweta Killa
Inside the best performing stocks of the Russell 2000 ETF.
Willis Towers (WLTW) Gains on Revenue Growth & Acquisitions
by Zacks Equity Research
Willis Towers Watson (WLTW) is poised to gain on increase in commissions and fees and strategic acquisitions.
Assurant (AIZ) Scales 52-Week High: Will the Rally Continue?
by Zacks Equity Research
Assurant (AIZ) reaches 52-week high, driven by strong-third-quarter results.
Arthur J. Gallagher (AJG) Unit Acquires Horseshoe Insurance
by Zacks Equity Research
Arthur J. Gallagher (AJG) unit completes the buyout of Horseshoe Insurance to expand in the ILS market.
Strategic Plans, Solid Capital Position Aid Assurant (AIZ)
by Zacks Equity Research
Assurant (AIZ) is poised to grow given its strategic initiatives and effective capital deployment.